ALB and Cirrhosis: No significant differences were observed in gender, insulin prescription, cirrhosis status, age, HCV genotype, total bilirubin, albumin levels, AST, ALT, baseline HCV RNA levels, posttreatment glucose levels, posttreatment HbA1c, hepatorenal biochemical parameters or insulin resistance indicators (as shown in Table 4).